Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 4, 2002, Pages 488-491

  Shaw, Kelly ^a   Turner, Jane ^a   Del Mar, Christopher ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

5 hydroxytryptophan; Depressive disorder; Tryptophan

Indexed keywords

5 HYDROXYTRYPTOPHAN; TRYPTOPHAN;

ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; VALIDATION PROCESS; VERTIGO;

5-HYDROXYTRYPTOPHAN; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 0036692489     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.01046.x     Document Type: Article

References (24)

1. The prevalence and distribution of major depression in a national community sample
2. Mental health and well-being: Profile of Australian adults
3. Drug treatment in psychiatry-psychotropic drugs
4. Unconventional medicine in the United States. Prevalence, costs, and patterns of use
5. Prevalence and cost of alternative medicine in Australia
6. Complementary therapies: The appeal to general practitioners
7. Complementary and alternative medicine: An educational, attitudinal and research challenge
8. Complementary therapies: Have they become accepted in general practice?
9. Belief systems of the general public concerning the appropriate treatments for mental disorders
10. Management of depression with serotonin precursors
11. St. John's wort for depression
12. Serotonin-Vorstufen als Antidepressiva: Eine Ubersicht
13. Control of brain neurotransmitter synthesis by precursor availability and nutritional state
14. Precursor control of neurotransmitter synthesis
15. Neurotransmitter precursors for the treatment of depression
16. Current status of the indolamine hypothesis of the affective disorders
17. L-Tryptophan and 5-hydroxytryptophan in the treatment of depression: A review
18. Characterization of contaminants in EMS-associated 1-tryptophan samples by high-performance liquid chromatography
19. Eosinophilia Myalgia Syndrome
20. Bias or biology: Evaluating the epidemiologic studies of 1-tryptophan and the eosinophilia-myalgia syndrome
21. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan
22. A pilot study of the predictive value of the probenecid test in application of 5-Hydroxytryptophan as antidepressant
23. The treatment of depression in general practice: A comparison of L-Tryptophan, Amitriptyline, and a combination of L-Tryptophan and Amitriptyline with placebo